Diagnostic Related Groups (DRGs) represent a bit of a paradox. On the one hand, they may lack clinical meaningfulness due to their wide grouping and categorization of services. On the other hand, the practice of classifying similar patients into clinically meaningful groups represents a potentially valuable new tool for providing cost-effective patient care.

Question

Given what we discussed about price transparency, do you think DRG's might influence or incentivize a specific diagnosis?